TAK-020 Relative Bioavailability and Food Effect Study in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 28, 2016

Primary Completion Date

August 5, 2016

Study Completion Date

August 24, 2016

Conditions
Healthy
Interventions
DRUG

TAK-020 Captisol Oral Solution

TAK-020 solution.

DRUG

TAK-020 CCT

TAK-020 co-crystal tablet

DRUG

TAK-020 SDT

TAK-020 Solid dispersion tablet.

DRUG

TAK-020 IRT

TAK-020 immediate release tablet.

DRUG

TAK-020 CCT

TAK-020 co-crystal tablet.

DRUG

TAK-020 Solid Formulation

TAK-020 solid formulation

Trial Locations (1)

Unknown

Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY